GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of genuine question about pharmacy that I am slightly embarrassed to ask — 8 comments in the full submission. View in context.
-28
c/glp1uk·submitted 2 years ago by u/vomit_free_since

genuine question about pharmacy that I am slightly embarrassed to ask

PSAbranch of 6 comments

genuine question about pharmacy that I am slightly embarrassed to ask. I am not trying to be the "source?" guy. I would just like a source. GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers. Discharged at goal back to the GP, who would not continue it. Nobody had mentioned…

Read the full submission and all 8 comments →

This branch

6 comments, started 2 years ago
u/jonas_cardoso11 points·2 years ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
u/vomit_free_sinceOP8 points·2 years ago

Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested.

replysharereportpermalink
u/ireland_drugs_pay3 points·2 years ago

keep every letter, the dates matter later

replysharereportpermalink
u/boots_or_bust1 point·2 years ago·edited

Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.

replysharereportpermalink
u/units_not_mgsyringe math0 points·2 years ago

Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.

replysharereportpermalink
[removed]1 point·2 years ago

[removed by moderator]

replysharereportpermalink

← back to the whole thread

About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.